PHRI Scientist Harriette Van Spall received the 2022 Canadian Institutes of Health Research (CIHR-ICRH) / Canadian Cardiovascular Society (CCS) Mid-Career Lecturer Award in Cardiovascular Sciences tonight at the Canadian Cardiovascular Congress in Ottawa.
Here is a small sample of Tweets on Van Spall’s presentation, “Obstacles are Opportunities to Soar.”
“I learned about problems in access .. aftermath of medical error .. gaps in ambulatory care .. how continuity of care is often lost”
👏 #CCCongress talk by Dr. @hvanspall, @CIHR_ICRH @SCC_CCS Mid-Career Lecturer in Cardiovascular Sciences.
“We have work to do to improve care.” pic.twitter.com/rNTJkk80Hr
— Dominique Vervoort (@DVervoort94) October 29, 2022
Deeply moved from @hvanspall talk for the mid-carrier lecturer award this morning at the #cccongress. As a PhD student aspiring for an academic position and as a woman, her talk really inspired me to further fight for women’s place in academia.@SCC_CCS pic.twitter.com/30sRV1d3lu
— Sarah O’Connor (@OConnorSarah3) October 29, 2022
CONGRATULATIONS to @hvanspall a ‘change agent’ for women in academia but also for the people seeking equitable health ‘care’ https://t.co/cCMhzd0WQL
— Carolyn Pullen, CEO (@SCC_CCS_CEO) October 29, 2022
As noted by CIHR , Van Spall has a strong record as a champion of diversity, equity and inclusion, as well as mentorship of many diverse Canadian and international trainees who have successfully won grant funding and published in top medical journals under her supervision.
Her research is funded by the Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada, and Ontario’s Ministry of Health and Long Term Care. She has garnered more than $5 million in operating grants and awards, and has published research in high-impact medical journals, including JAMA, Lancet, European Heart Journal, Circulation, and JACC.
The same week as this CIHR/CCS Award, Van Spall received the American Heart Association’s Dr. Nanette Wenger “Research in Red” Award for best article on CVD and women.